References
- Bobba S, Di Girolamo N, Munsie M, et al. The current state of stem cell therapy for ocular disease. Exp Eye Res. 2018; 177: 65–75.
- Henig I, Zuckerman T. Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Med J. 2014;5(4):e0028.
- Cossu G, Birchall M, Brown T, et al. Lancet commission: stem cells and regenerative medicine. Lancet. 2018; 391(10123): 883–910.
- Di Girolamo N, Bosch M, Zamora K, et al. A contact lens-based technique for expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction. Transplantation. 2009; 87(10): 1571–1578.
- Shortt AJ, Tuft SJ, Daniels JT. Corneal stem cells in the eye clinic. Br Med Bull. 2011; 100(1): 209–225.
- Zhao Y, Ma L. Systemic review and meta-analysis on transplantation of ex vivo LESC on amniotic membrane in limbal stem cell deficiency. Cornea. 2015; 34: 9.
- Utheim T. Limbal epithelial cell therapy. Methods Mol Biol. 2013; 1014: 41.
- Agency EM Holoclar® – European Public Assessment Report 2014 [updated 2014 December 18]. Available from: https://www.ema.europa.eu/en/documents/assessment-report/holoclar-epar-public-assessment-report_en.pdf.
- Miotti G, Parodi PC, Zeppieri M. Stem cell therapy in ocular pathologies in the past 20 years. World J Stem Cells. 2021; 13(5): 366–385.
- Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2): 377–381.
- Obo Australia. Optometry of Australia registered data . 1 January- 31 March 2021. Available from: https://www.optometryboard.gov.au/about/statistics.aspx.
- Le Q, Chauhan T, Yung M, et al. Outcomes of limbal stem cell transplant: a meta-analysis. JAMA Ophthalmol. 2020; 138(6): 660–670.
- Sacchetti M, Rama P, and Bruscolini A, et al. Limbal stem cell transplantation: clinical results, limits, and perspectives. Stem Cells Int. 2018; 2018: 8086269.
- Pellegrini G, Traverso CE, Franzi AT, et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 1997; 349(9057): 990–993.
- O’-Neill HC, Limnios IJ, Barnett NL. Advancing a stem cell therapy for age-related macular degeneration. Curr Stem Cell Res Ther. 2020; 15(2): 89–97.
- Song WK, Park K-M, Kim H-J, et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Reports. 2015; 4(5): 860–872.
- Sharma A, Jaganathan BG. Stem cell therapy for retinal degeneration: the evidence to date. Biologics. 2021; 15: 299–306.
- Georgiou M, Fujinami K, Michaelides M. Inherited retinal diseases: therapeutics, clinical trials and end points—a review. Clin Experiment Ophthalmol. 2021; 49(3): 270–288.
- Hu ML, Edwards TL, O’-Hare F, et al. Gene therapy for inherited retinal diseases: progress and possibilities. Clin Exp Optometry. 2021; 104(4): 444–454.
- Vázquez-Domínguez I, Garanto A, Collin RWJ. Molecular therapies for inherited retinal diseases-current standing, opportunities and challenges. Genes (Basel). 2019; 10(9): 654.
- Baiula M, Spampinato S. Experimental pharmacotherapy for dry eye disease: a review. J Exp Pharmacol. 2021; 13: 345–358.
- Harrell CR, Fellabaum C, Arsenijevic A, et al. Therapeutic potential of mesenchymal stem cells and their secretome in the treatment of glaucoma. Stem Cells Int. 2019; 2019: 7869130.
- Coulon SJ, Schuman JS, Du Y, et al. A novel glaucoma approach: stem cell regeneration of the trabecular meshwork. Prog Retin Eye Res. 2022; 101063.
- Dewi CU, and O’Connor MD. Use of human pluripotent stem cells to define initiating molecular mechanisms of cataract for anti-cataract drug discovery. Cells. 2019; 8(10): 1269.
- Lyu D, Zhang L, Qin Z, et al. Modeling congenital cataract in vitro using patient-specific induced pluripotent stem cells. NPJ Regen Med. 2021; 6(1): 60.
- Cui Y, De Souza N, Wilson D, et al. The impact of continuing professional development on ophthalmic dispensing of progressive addition lenses in the Asia–Pacific region. Clin Exp Optometry. 2011; 94(2): 219–222.
- Ramani S, McMahon GT, Armstrong EG. Continuing professional development to foster behaviour change: from principles to practice in health professions education. Med Teach. 2019; 41(9): 1045–1052.
- Filipe HP, Silva ED, Stulting AA, et al. Continuing professional development: best practices. Middle East Afr J Ophthalmol. 2014; 21(2): 134–141.
- Douglass A, Keller PR, He M, et al. Knowledge, perspectives and clinical practices of Australian optometrists in relation to childhood myopia. Clin Exp Optometry. 2020; 103(2): 155–166.
- Downie LE, Keller PR, Vingrys AJ. An evidence-based analysis of Australian optometrists’ dry eye practices. Optom Vis Sci. 2013; 90(12): 1385–1395.
- Suttle CM, Jalbert I, Alnahedh T. Examining the evidence base used by optometrists in Australia and New Zealand. Clin Exp Optometry. 2012; 95(1): 28–36.
- Sa Bentley, Black A, Khawaja N, et al. The mental health and wellbeing survey ofAustralian optometrists. Ophthalmic Physiol Opt. 2021; 41(4): 798–807.
- Downie LE, Keller PR. The self-reported clinical practice behaviors of Australian optometrists as related to smoking, diet and nutritional supplementation. PLoS One. 2015; 10(4): e0124533.